Christl Julia, Supprian Tillmann
Abteilung Gerontopsychiatrie, LVR-Klinikum Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf, Bergische Landstr. 2, 40629, Düsseldorf, Deutschland.
Nervenarzt. 2024 Jan;95(1):41-45. doi: 10.1007/s00115-023-01601-5. Epub 2024 Jan 8.
Lithium is considered the gold standard for the treatment of bipolar affective disorder for the prevention of recurrence of manic and depressive episodes and for augmentation treatment in unipolar severe depressive episodes. The indications for treatment with lithium do not differ for older or younger patients. Nevertheless, there are a number of aspects to be considered with respect to drug safety in the group of old patients.
The aim was to give an overview of the current literature on lithium treatment in old age and from this to derive recommendations for action.
A selective literature review on lithium treatment in old age was conducted to answer questions on drug safety, monitoring (particularly with respect to comorbidities) and potential alternatives to lithium.
Lithium is an effective and, if used correctly, safe drug also in old people; however, with respect to somatic comorbidities that increase with age, special caution is required when using lithium in order to prevent nephropathy and intoxication.
锂盐被认为是治疗双相情感障碍以预防躁狂和抑郁发作复发以及用于单相重度抑郁发作强化治疗的金标准。锂盐治疗的适应证在老年患者和年轻患者中并无差异。然而,在老年患者群体中,有许多药物安全性方面的问题需要考虑。
旨在概述当前关于老年患者锂盐治疗的文献,并据此得出行动建议。
对老年患者锂盐治疗进行了选择性文献综述,以回答有关药物安全性、监测(尤其是合并症方面)以及锂盐潜在替代药物的问题。
锂盐对老年人也是一种有效且使用正确时安全的药物;然而,鉴于随着年龄增长而增加的躯体合并症,使用锂盐时需要特别谨慎,以预防肾病和中毒。